ANN D. RHOADS - 07 Nov 2025 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Role
Director
Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Issuer symbol
GMED
Transactions as of
07 Nov 2025
Transactions value $
-$818,000
Form type
4
Filing time
10 Nov 2025, 16:15:55 UTC
Previous filing
16 Sep 2025
Next filing
10 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
RHOADS ANN D Director VALLEY FORGE BUSINESS CENTER, 2560 GENERAL ARMISTEAD AVENUE, AUDUBON /s/ Kelly G. Huller, Attorney-in-Fact 10 Nov 2025 0001250252

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GMED Class A Common Stock Sale -$648K -8K -31.52% $81.00 17.4K 07 Nov 2025 Direct F1
transaction GMED Class A Common Stock Sale -$170K -2K -11.5% $85.00 15.4K 10 Nov 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan dated November 8, 2024 executed by the reporting person.